Renal Cancer Drug Pipeline Update Lists All Drugs and Gives You a Progress Analysis on Each One of Them
Posted on: Tuesday, 28 August 2007, 06:13 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c66820) has announced the addition of "Renal Cancer Drug Pipeline Update 2007" to their offering.
The high existing unmet need in the treatment of renal cancer is reflected by the poor prognosis of patients with advanced stage disease, five- year survival rates with existing cytokine therapy being less than 20% (RCC) in this patient cohort. The identification of biomarkers is set to revolutionize patient staging and prognosis by individualizing patient treatments and creating novel drug targets.
There are today more than 150 therapeutics targeting renal cancer, from early preclinical to marketed drugs. Renal Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 116 different targets. These targets are further categorized on the CD-ROM by 38 classifications of molecular function and their possible belonging to 20 different signalling pathways in the cell. Read more below on how the Renal Cancer Drug Pipeline Update is organized.
How May Drug Pipeline Update Be of Use?
-Show investors/board/management that you are right on top of drug development progress in your therapeutic area.
-Find competitors, collaborations partners, M&A candidates etc.
-Jump start competitive drug intelligence operations
-Excellent starting point for world wide benchmarking
-Compare portfolio and therapy focus with your peers
-Speed up pro-active in-/out licensing strategy work
-Fast and easy way of tracking drugs using search engines; just one click and you may search the World Wide Web and PubMed for any drug.
-Drug Pipeline Update is delivered to you as a CD-ROM application, which requires no installation on your computer. Please read more about application features and system requirements below.
Drug Pipeline Update at a Glance
Investigators Includes more than 115 principal investigators plus their collaborators. There is direct access from inside the application to web pages of all principal investigators.
Note: You are able to sort and find drugs according to investigators and partners from drop-down menus in the application. You may also sort and find drugs according to country of investigator.
Drug name & Synonyms Lists commercial, generic and code names for drugs. In all more than 300 names
Developmental stage This Drug Pipeline Update contains more than 150 drugs in active development for the treatment of renal cancer:
14 marketed drugs
9 drugs in Phase III
> 65 drugs in Phase II
> 40 drugs in Phase I
> 15 drugs in Preclinical
Note: You are able to sort and find drugs according to developmental stage from drop-down menu in the application.
Indications Included renal cancer drugs are also in development for over 90 other indications.
Note: You are able to sort and find drugs according to type of indication from drop-down menu in the application.
For more information visit http://www.researchandmarkets.com/reports/c66820
Source: Business Wire
Related Articles
- Provides Insight into the Drug Pipeline Status of Pancreatic Cancer Drugs By Company and By Stage
- New Report Examines the Gastrointestinal (Stomach) Cancer Drug Pipeline
- New Report Examines the Current Ovarian Cancer Drug Pipeline
- New Report Examines the Current Liver Cancer Drug Pipeline
- The Colorectal Drug Pipeline Update 2007 Lists All Drugs and Gives You a Progress Analysis on Each One
- Gain an In-Depth Insight into the Breast Cancer Drug Pipeline With New Report
- Data Show Geron's Telomerase Inhibitor Cancer Drug is Active Against Cancer Stem Cells From Multiple Myeloma Patients
- Hematological Cancers Drug Pipeline Update 2006 Lists More Than 230 Drugs and Gives You a Progress Analysis on Each One of Them
- Lung Cancer Drug Pipeline Update Lists All 243 Drugs for Lung Cancer and Gives You a Progress Analysis on Each One of Them
 |
 |
User Comments (0)
RSS Feeds